CTA
RMD icon

Colonial Trust Advisors’s ResMed RMD Stock Holding History

Colonial Trust Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10
Closed -$1.94K – 767
2024
Q2 		$1.94K Sell
10
-2
-17% -$406 ﹤0.01% 679
2024
Q1 		$2.39K Sell
12
-15
-56% -$2.75K ﹤0.01% 781
2023
Q4 		$4.66K Buy
27
+15
+125% +$2.31K ﹤0.01% 619
2023
Q3 		$1.78K Buy
12
+11
+1,100% +$1.99K ﹤0.01% 735
2023
Q2 		$219 Hold
1
– – ﹤0.01% 876
2023
Q1 		$219 Hold
1
– – ﹤0.01% 859
2022
Q4 		$208 Buy
+1
New +$220 ﹤0.01% 867

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Colonial Trust Advisors's RMD Position: Q3 2024 in Review

Colonial Trust Advisors sold out of ResMed (RMD) in Q3 2024, closing a stake of 10 shares — an estimated $1.94K sold.

Colonial Trust Advisors first reported a position in RMD in Q4 2022 and held it in 7 quarters. The position peaked at $4.66K in Q4 2023. 801 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

  • Colonial Trust Advisors reported no remaining ResMed position as of Q3 2024 after selling out during the quarter.
  • Colonial Trust Advisors sold 10 ResMed shares in Q3 2024, an estimated $1.94K.
  • Colonial Trust Advisors first reported a position in ResMed in Q4 2022 and held it in 7 quarters.
  • Colonial Trust Advisors's ResMed position peaked at $4.66K in Q4 2023.
  • 801 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on Colonial Trust Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.